Compare MOMO & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MOMO | INDV |
|---|---|---|
| Founded | 2011 | 1994 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 4.1B |
| IPO Year | 2014 | N/A |
| Metric | MOMO | INDV |
|---|---|---|
| Price | $6.98 | $32.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $13.00 | ★ $35.75 |
| AVG Volume (30 Days) | 948.7K | ★ 2.9M |
| Earning Date | 03-11-2026 | 02-19-2026 |
| Dividend Yield | ★ 4.29% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.60 | ★ 0.98 |
| Revenue | ★ $1,464,746,462.00 | $1,180,000,000.00 |
| Revenue This Year | N/A | $2.27 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $11.56 | $33.16 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.12 | $7.62 |
| 52 Week High | $9.22 | $38.00 |
| Indicator | MOMO | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 59.27 | 30.31 |
| Support Level | $6.55 | $33.76 |
| Resistance Level | $7.11 | $36.22 |
| Average True Range (ATR) | 0.17 | 1.20 |
| MACD | 0.05 | -0.55 |
| Stochastic Oscillator | 83.46 | 4.91 |
Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines, out of which Momo's service lines segment derives the majority of revenue.
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.